Experimental Schistosoma bovis infection in goats: pathological consequences of praziquantel treatment.
Schistosoma bovis-infected goats were treated with praziquantel (60 mg/kg) and killed for examination 1, 7 or 28 days later. Infected non-treated goats and parasite-free, treated or non-treated goats were included for comparison. The gross pathological changes seen in the infected non-treated groups were mild to moderate. The liver appeared discoloured and moderately enlarged. The intestinal lesions were most prominent in the small intestines, which showed catarrhal inflammation with numerous tiny corpuscles beneath the luminal surface. The mesenteric lymph nodes were slightly to moderately enlarged. In contrast, on macroscopical examination, the infected treated groups invariably showed pronounced liver changes and marked enlargement of the lymph nodes, whereas the lesions in the intestines were comparatively slight. Histological lesions related to dead worms were seen in the livers of all treated animals. These lesions included pronounced inflammatory cellular infiltrates, thrombophlebitis, necrosis and periportal fibrosis, still severe 4 weeks after treatment. In the intestines, the deposition of new eggs with little cellular reaction had almost completely ceased 1 week after treatment. Four weeks after treatment, only a very few egg-associated lesions were noted in the intestines. The presence of severe lesions attributable to dead worms in the liver indicates the need for caution when treating animals with high worm loads or concomitant liver disease.
Johansen
M V
MV
Danish Bilharziasis Laboratory, Charlottenlund, Denmark.
Monrad
J
J
Christensen
N O
NO
Lindberg
R
R
D000818:Animals; D000980:Antiplatyhelmintic Agents / Q000633:toxicity*; D005260:Female; D006041:Goats; D006099:Granuloma / Q000209:etiology; D007422:Intestines / Q000473:pathology; D008099:Liver / Q000469:parasitology / Q000473:pathology; D008107:Liver Diseases / Q000209:etiology; D008198:Lymph Nodes / Q000473:pathology; D008297:Male; D011223:Praziquantel / Q000633:toxicity*; D012552:Schistosomiasis / Q000188:drug therapy* / Q000473:pathology*; D013997:Time Factors
D000980:Antiplatyhelmintic Agents; D011223:Praziquantel